Published in Hepatitis Weekly, February 2nd, 1998
The letter confirmed the FDA's receipt of the NDA on December 5, 1997, and that the "priority" therapeutic classification has been assigned. In accordance with federal regulation (21 CPR 31.1O1) the FDA has 60 days from the date of receipt to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.